Clinical trialNCT05524532CompletedPhase 3Interventional

Effects of Immulina TM Supplements With PASC Patients

SponsorUniversity of Mississippi Medical CenterEnrollment101Post Acute COVID-19 Syndrome

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a multi-site study that will try to determine the effects of Immulina ™, a natural dietary supplement, on blood chemicals associated with inflammation that are often increased in patients with long COVID (also called PASC).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Gailen D Marshall, Jr., MD, PhD
University of Mississippi Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico

University of Puerto Rico
San Juan, Puerto Rico, Puerto Rico

United States

University of Hawaii
Honolulu, Hawaii, United States
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States
Louisiana State University
New Orleans, Louisiana, United States
Mainehealth
Portland, Maine, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
University of Oklahoma
Oklahoma City, Oklahoma, United States
West Virginia University
Morgantown, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Immulina TM

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 20 Jul 2023
Primary completion: 29 Jul 2025
Completion: 29 Jul 2025
Last update posted: 31 Jul 2026
Registered enrollment: 101
Registry id: NCT05524532

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.